Efficacy of Immediate Switching from Bicalutamide to Flutamide as Second-Line Combined Androgen Blockade

Table 1

Patient characteristics ().

Mean age, years (range)	70.9	(52–92)
Mean PSA at the diagnosis, ng/mL (range)	760	(17.2–5740)
Clinical stage, (%)
T2	1 (5)
T3	11 (55)
T4	8 (40)
Gleason score, (%)
≤6	1 (5)
7	3 (15)
8	4 (20)
9	11 (55)
10	1 (5)
Response to first-line CAB therapy, (%)
Response	17 (85)
PR	3 (15)

CAB: combined androgen blockade; PR: partial remission.